SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-123266
Filing Date
2024-11-07
Accepted
2024-11-07 16:05:04
Documents
6
Period of Report
2024-11-07

Document Format Files

Seq Description Document Type Size
1 6-K q3_2024_6-k_mda_pr.htm 6-K 30077
2 EX-99.1 ocs-ex99_1.htm EX-99.1 1276030
3 EX-99.2 ocs-ex99_2.htm EX-99.2 532709
4 EX-99.3 ocs-ex99_3.htm EX-99.3 207957
5 GRAPHIC img187686630_0.jpg GRAPHIC 11150
6 GRAPHIC img189533672_0.jpg GRAPHIC 8129
  Complete submission text file 0000950170-24-123266.txt   2074622
Mailing Address BAHNHOFSTRASSE 7 ZUG V8 6300
Business Address BAHNHOFSTRASSE 7 ZUG V8 6300 617-937-2423
Oculis Holding AG (Filer) CIK: 0001953530 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41636 | Film No.: 241435485
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)